chr19-49873034-T-G

Variant summary

Our verdict is Uncertain significance. The variant received 2 ACMG points: 4P and 2B. PM1PM2BP4_Moderate

The NM_001098633.4(AKT1S1):​c.262A>C​(p.Ser88Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000071 in 1,408,948 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S88C) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 7.1e-7 ( 0 hom. )

Consequence

AKT1S1
NM_001098633.4 missense

Scores

5
14

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.866

Publications

0 publications found
Variant links:
Genes affected
AKT1S1 (HGNC:28426): (AKT1 substrate 1) AKT1S1 is a proline-rich substrate of AKT (MIM 164730) that binds 14-3-3 protein (see YWHAH, MIM 113508) when phosphorylated (Kovacina et al., 2003 [PubMed 12524439]).[supplied by OMIM, Mar 2008]
PNKP (HGNC:9154): (polynucleotide kinase 3'-phosphatase) This locus represents a gene involved in DNA repair. In response to ionizing radiation or oxidative damage, the protein encoded by this locus catalyzes 5' phosphorylation and 3' dephosphorylation of nucleic acids. Mutations at this locus have been associated with microcephaly, seizures, and developmental delay.[provided by RefSeq, Sep 2010]
PNKP Gene-Disease associations (from GenCC):
  • ataxia - oculomotor apraxia type 4
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P, Laboratory for Molecular Medicine
  • microcephaly, seizures, and developmental delay
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Charcot-Marie-Tooth disease type 2B2
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 2 ACMG points.

PM1
In a modified_residue Phosphoserine (size 0) in uniprot entity AKTS1_HUMAN
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.2085773).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AKT1S1NM_001098633.4 linkc.262A>C p.Ser88Arg missense_variant Exon 2 of 5 ENST00000344175.10 NP_001092103.1 Q96B36-1A0A024QZF6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AKT1S1ENST00000344175.10 linkc.262A>C p.Ser88Arg missense_variant Exon 2 of 5 3 NM_001098633.4 ENSP00000341698.5 Q96B36-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.00000605
AC:
1
AN:
165368
AF XY:
0.0000114
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000388
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
7.10e-7
AC:
1
AN:
1408948
Hom.:
0
Cov.:
34
AF XY:
0.00000144
AC XY:
1
AN XY:
696192
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
32102
American (AMR)
AF:
0.0000270
AC:
1
AN:
37028
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25172
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36616
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79970
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48476
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5504
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1085658
Other (OTH)
AF:
0.00
AC:
0
AN:
58422
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.375
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000756
ExAC
AF:
0.0000171
AC:
2

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.27
BayesDel_addAF
Benign
-0.25
T
BayesDel_noAF
Benign
-0.47
CADD
Benign
16
DANN
Uncertain
1.0
DEOGEN2
Benign
0.26
T;T;T;T;T;.;.
Eigen
Benign
-0.45
Eigen_PC
Benign
-0.44
FATHMM_MKL
Uncertain
0.78
D
LIST_S2
Benign
0.73
T;.;.;.;.;T;T
M_CAP
Uncertain
0.12
D
MetaRNN
Benign
0.21
T;T;T;T;T;T;T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
0.90
L;L;L;L;L;.;.
PhyloP100
0.87
PrimateAI
Uncertain
0.71
T
PROVEAN
Benign
-1.1
N;N;N;N;N;N;N
REVEL
Benign
0.063
Sift
Uncertain
0.023
D;D;D;D;D;D;D
Sift4G
Benign
0.24
T;T;T;T;T;T;.
Polyphen
0.68
P;P;P;P;P;.;.
Vest4
0.32
MutPred
0.29
Loss of glycosylation at S88 (P = 5e-04);Loss of glycosylation at S88 (P = 5e-04);Loss of glycosylation at S88 (P = 5e-04);Loss of glycosylation at S88 (P = 5e-04);Loss of glycosylation at S88 (P = 5e-04);.;Loss of glycosylation at S88 (P = 5e-04);
MVP
0.59
MPC
0.42
ClinPred
0.13
T
GERP RS
2.0
Varity_R
0.058
gMVP
0.19
Mutation Taster
=84/16
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs376054064; hg19: chr19-50376291; API